Previous Article | Next Article ![]()
Infection and Immunity, August 2005, p. 4972-4981, Vol. 73, No. 8
0019-9567/05/$08.00+0 doi:10.1128/IAI.73.8.4972-4981.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Departments of Microbiology and Immunology,1 Pathology, New York Medical College, Valhalla, New York 105952
Received 11 January 2005/ Returned for modification 1 March 2005/ Accepted 14 March 2005
|
|
|---|
|
|
|---|
(p)ppGpp acts as a global transcriptional regulator. The general effect of the stringent response is a decrease in rRNA, tRNA, and protein synthesis and a decrease in growth rate that results in bacterial adaptation to an environment scarce in nutrients (6). (p)ppGpp also influences many other bacterial physiological functions including competence (23), morphological and physiological differentiation and production of clavulanic acid and cephamycin C (25, 26), production of actinorhodin and undecylprodigiosin antibiotics (46), thermotolerance (48), adaptation to oxidative stress (30), and sensitivity to antibiotics. As regards the latter, E. coli strains able to synthesize (p)ppGpp in either a RelA- or a SpoT-dependent manner show a greater resistance to antimicrobials than strains that cannot produce (p)ppGpp (17). In E. coli, production of (p)ppGpp is also required for the accumulation of inorganic polyphosphate needed for degradation of proteins during starvation mediated by the Lon protease (28), and lack of inorganic polyphosphate synthesis in enteric bacteria is accompanied by a reduction in virulence (27).
The relA and spoT gene products and (p)ppGpp mediate important aspects of virulence in a number of pathogens (8, 20, 34). For example, Vibrio cholerae relA is involved in the ability of V. cholerae to display pathogenicity in in vitro and in vivo models of infection (20), Mycobacterium tuberculosis rel-mediated adaptation to stationary phase is critical to long-term persistence of M. tuberculosis in mice (8), and mutations in Salmonella enterica serovar Typhimurium relA and spoT result in attenuation in animals (34). Not all rel mutants show decreased virulence. Mutation of Listeria monocytogenes relA, while accompanied by loss of (p)ppGpp synthesis and a decrease in osmotolerance, does not diminish in vivo virulence (32).
Borrelia burgdorferi is the etiologic agent of Lyme disease (44). During its life cycle, this spirochete thrives in both ticks and mammals and is able to adapt to various environmental conditions, including changes in temperature, pH, osmolarity, and nutrient availability (10, 41). Preliminary work by ourselves and others has indicated that the stringent response is likely to be present in B. burgdorferi (3, 4, 7). The B. burgdorferi genome contains a single chromosomal rel gene (BB0198) (B. burgdorferi rel [relBbu]) that shows 35 and 39% amino acid homology, respectively, to E. coli relA and spoT (13). Microarray studies have shown increased expression of relBbu mRNA in B. burgdorferi grown in BSK-H at pH 7.5 and 23°C (unfed tick conditions) compared to B. burgdorferi grown in BSK-H at pH 6.8 and 37°C (fed tick conditions) or in rat peritoneal chambers (37). (p)ppGpp synthesis by B. burgdorferi and the ability of relBbu to complement a relA-spoT E. coli double mutant for growth on minimal medium (3, 4, 7) provide additional support for the existence of a functional stringent response in B. burgdorferi mediated by the product of relBbu. We previously suggested that the stringent response in B. burgdorferi could modulate expression of bmpD, a lipoprotein gene jointly transcribed with the ribosomal protein genes rpsL and rpsG (3, 11). The discovery that B. burgdorferi RpoS (
S) is responsible for the expression of OspC, the adhesin crucial for the ability of B. burgdorferi to infect the mammalian host (18, 33) and evidence from other bacterial systems that (p)ppGpp is a positive regulator of rpoS expression (16), strongly suggests that (p)ppGpp might modulate expression of lipoproteins involved in the B. burgdorferi life cycle and virulence (22).
To confirm that relBbu is necessary for (p)ppGpp production in B. burgdorferi and to clarify its role in B. burgdorferi physiology, relBbu was deleted in infectious B. burgdorferi 297. This deletion was complemented extrachromosomally, and the B. burgdorferi derivatives obtained were assayed for relBbu mRNA transcription, RelBbu protein synthesis, and the ability to produce (p)ppGpp. Growth characteristics, OspA and OspC protein levels, bmp mRNA levels, sensitivity to antibiotics, and virulence in mice were also compared between wild-type, mutant, and complemented strains. The relBbu gene was clearly responsible for (p)ppGpp synthesis. Its deletion affected B. burgdorferi growth in vitro and ablated in vivo virulence in mice. In contrast, deletion of relBbu did not alter OspA protein levels, bmp gene expression, or B. burgdorferi antibiotic susceptibility and did not eliminate the temperature-elicited OspC shift, suggesting that the role of (p)ppGpp in B. burgdorferi physiology is different from that in E. coli.
|
|
|---|
(GIBCO/Life Technologies, Grand Island, NY) grown in the presence of spectinomycin, 100 µg/ml (Sigma), was used for propagation of the pKFSS1 and pKFSS1-relBbu plasmids. Generation of relBbu deletion. Deletion of B. burgdorferi relBbu was done by homologous recombination with a relBbu inactivation construct (Fig. 1) using PCR-based fusions (43). In brief, nucleotides 195216 to 195852 (primers 1 and 2) (Table 1) and nucleotides 197417 to 198004 (primers 3 and 4) (Table 1) were amplified from B. burgdorferi chromosomal DNA, and the kanamycin resistance gene aph(3')-IIIa from Enterococcus faecalis with its own promoter was amplified from plasmid pBLS500 (primers III and IV) (Table 1). All PCR assays used an initial denaturation at 94°C for 2 min and 32 cycles of 94°C for 15 s, annealing at 56°C for 20 s, and extension at 68°C for 3 min. The three amplicons were fused (43), and the final PCR product containing the relBbu inactivation construction was precipitated with ethanol and resuspended in sterile water at 4 µg/µl. Forty micrograms was used for each transformation (38).
![]() View larger version (12K): [in a new window] |
FIG. 1. Production of the B. burgdorferi 297 relBbu deletion mutation by replacement of central region of relBbu with the kanamycin resistance gene aph(3')-IIIa (Km) from Enterococcus faecalis (43). Numbers showing the positions of nucleotides on B. burgdorferi chromosome indicate the start and the end of relBbu gene and positions of flanking relBbu fragments used in inactivation construction. Primers used for analysis of relBbu deletion are shown by arrows. wt, wild type.
|
|
View this table: [in a new window] |
TABLE 1. Primers used in this study
|
to obtain pKFSS1-relBbu encoding relBbu under its own promoter; 10 µg of this plasmid was electroporated into B. burgdorferi (38). Transformation of B. burgdorferi with pKFSS1 was used as a control.
Confirmation of relBbu inactivation and complementation in B. burgdorferi.
DNA from B. burgdorferi transformants was purified (High Pure PCR template preparation kit; Roche Diagnostics Corporation, Indianapolis, IN) and analyzed by PCR (primers R/SpPROT1S and R/SpPROT1EndA) (Table 1 and Fig. 1) to confirm the presence of the relBbu deletion or complementation. The PCR fragment obtained with primers relBbu 6kbL and relBbu 6kbR (Table 1; Fig. 1) was sequenced using primers R/SpPROT1S and R/SpPROT1EndA (Table 1; Fig. 1) to provide further confirmation of the relBbu deletion (Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY). DNA from complemented B. burgdorferi strains was transformed into E. coli DH5
. DNA from E. coli clones selected on spectinomycin plates was subjected to restriction analysis using BamHI and PstI for comparison with the plasmids originally used for electroporation of B. burgdorferi.
Estimation of pKFSS1-relBbu copy number. A competitive PCR assay was used to determine the pKFSS1-relBbu copy number in complemented B. burgdorferi 297. Competitors for flaB and relBbu genes containing internal deletions were constructed as previously described (3, 39). Serial twofold dilutions of competitors were mixed with fixed amounts of total 297 DNA to perform quantitative PCR for flaB and relBbu. Primers 49 and 50 (Table 1) were used for flaB detection; primers ST3 and ST4 (Table 1) were used for relBbu detection. Target DNA and competitor DNA were assumed to be present at equimolar concentrations in those reactions when the competitor and target PCR products were at similar intensities in agarose gels (11).
Determination of B. burgdorferi plasmid content. The plasmid content in B. burgdorferi relBbu mutants and complemented strains was compared with that of the wild-type parental strain using PCR as described previously (24).
RNA isolation, RT-PCR, and competitive RT-PCR. Total RNA from late-log-phase B. burgdorferi was isolated with TRizol reagent (Invitrogen Life Technology, Carlsbad, CA) according to the manufacturer's recommendations and was treated with RQ1 RNase-free DNase (Promega Corporation, Madison, WI) to eliminate DNA contamination. Reverse transcription (RT)-PCR was performed using the Access RT-PCR system (Promega) according to the manufacturer's recommendations (3, 11). Primers ST3 and ST4 (Table 1) were used for relBbu mRNA detection; primers 49 and 50 (Table 1) were used for detection of the constitutively expressed flaB gene as a control to show the presence of RNA in a sample (11). Primers BB0199RT_R and BB0199RT_F (Table 1) were used for detection of mRNA for the BB0199 gene. Primers and conditions for competitive RT-PCR for bmp genes have been described previously (3, 11).
Detection of B. burgdorferi proteins. Anti-RelBbu antibodies were raised in rabbits immunized with recombinant RelBbu protein (A. V. Bryksin, T. N. Orlova, and F. C. Cabello, unpublished data). Rabbit anti-FlaB antibodies were provided by J. D. Radolf, University of Connecticut, Farmington, CT; mouse monoclonal anti-OspA antibodies (H5332) were provided by A. G. Barbour, University of California, Irvine, CA; mouse monoclonal anti-OspC antibodies were provided by R. D. Gilmore, Centers for Disease Control and Prevention, Fort Collins, CO; and mouse monoclonal anti-RpoS antibodies (6A7-101-H11) were provided by M. V. Norgard, University of Texas Southwestern Medical Center, Dallas, TX. FlaB, OspA, OspC, RelBbu, and RpoS proteins were detected in B. burgdorferi lysates by Western blot analysis and the ECF Western blotting kit (Amersham Biosciences, Piscataway, NJ) and quantified using a Storm 860 PhosphorImager and ImageQuaNT software (Molecular Dynamics, Sunnyvale, CA).
Detection of (p)ppGpp. B. burgdorferi (5 x 106 cells/ml) was incubated in BSK-H at 34°C containing 10 µCi/ml of uniformly labeled [32P]orthophosphate (Amersham) for 2 days. Labeled cells were harvested from 10-ml cultures, and (p)ppGpp was extracted and chromatographed on cellulose polyethyleneimine thin-layer chromatography (TLC) plates (Selecto Scientific, Suwanee, GA.) (3). Plates were air dried, exposed to a phosphor screen (Molecular Dynamics) for 12 to 24 h, and scanned using a Storm 860 PhosphorImager.
B. burgdorferi growth assays.
Wild-type,
relBbu, and complemented B. burgdorferi strains (104 cells/ml) were grown at 34°C in BSK-H for 30 days. Cell numbers were determined by dark-field microscopy every other day during the first 2 weeks of growth. To measure the effect of cell death in B. burgdorferi stationary-phase cultures, the number of viable organisms present in each culture was determined by limiting dilution at day 30 and compared to the number of cells counted microscopically at day 14. Limiting dilution was performed using serial fourfold dilutions of 30-day-old cultures with fresh BSK-H in 96-well plates (180 µl/well; initial dilution, 1:4; final dilution, 1:16,777,216). The highest dilution yielding positive cultures was determined after two additional weeks of growth at 34°C, and the number of cells/ml in the culture on day 30 was calculated assuming that one cell was sufficient to produce cell growth in a well. The data are presented as the cell survival index (as a percentage) = viable cells/mlDay 30 (by limiting dilution)/Total cells/mlday 14 (by microscopy) x 100 and are presented as means ± standard deviations. Limiting dilution analysis and microscopy were done in duplicate in each of two independent experiments. Results were analyzed statistically using a one-way analysis of variance.
B. burgdorferi temperature shift.
B. burgdorferi was grown at 34°C in BSK-H to 107 cells/ml, then inoculated at an initial concentration of 106 cells/ml, and grown at 23°C. After 1 week at 23°C, B. burgdorferi was transferred to fresh BSK-H at 23°C, 34°C, and 37°C at an initial concentration of 103 cells/ml. Cells were collected when their concentration reached 3 x 107 cells/ml for the wild-type parent and 107 cells/ml for
relBbu. In other temperature shift experiments, B. burgdorferi was grown at 34°C as described above, then transferred to BSK-H at 37°C, and collected at early stationary phase when cell concentrations reached 108 cells/ml for the wild-type parent, 2 x 107 cells/ml for the relBbu mutant and the mutant complemented with the empty pKFSS1 vector, and 5 x 107 cells/ml for the mutant complemented with pKFSS1-relBbu.
Antibiotic sensitivity.
MICs of ampicillin, ciprofloxacin, erythromycin, tetracycline, and vancomycin (Sigma) were determined for wild-type,
relBbu, and complemented B. burgdorferi in BSK-H. B. burgdorferi (105 cells/ml) in BSK-H was added to serial threefold dilutions of each antibiotic (initial concentration, 600 µg/ml; final concentration, 0.01 µg/ml) or no antibiotic in 96-well plates. The plates were incubated for 2 weeks at 32°C in a humidified 3% CO2 atmosphere. The MIC was defined as the smallest antibiotic concentration preventing B. burgdorferi growth under these conditions.
Infection of mice with B. burgdorferi. Four groups of 4-week-old C3H/HeN mice (Charles River Laboratory, Wilmington, MA) were infected intradermally with B. burgdorferi 297 wild type (five mice), relBbu mutant (four mice), relBbu mutant transformed with pKFSS1 (four mice), and complemented relBbu mutant (four mice) using 104 cells/mouse. Two weeks after infection, the mice were sacrificed, and ear punches and blood samples (100 µl) were taken and cultured for 2 weeks at 34°C in 1.5 ml of BSK-H containing 50 µg/ml of rifampin (Merrell Dow Pharmaceuticals, Inc., Cincinnati, OH) and 2.5 µg/ml of amphotericin B (Sigma) before being microscopically examined for growth of B. burgdorferi.
|
|
|---|
relBbu produced a shorter PCR fragment than the fragment generated by the same primers in the wild-type B. burgdorferi (Fig. 2A). Only 2 of the 20 mutants had all the plasmids of parental B. burgdorferi 297. PCR revealed that the parental and these two relBbu B. burgdorferi mutants lacked the lp56, lp38, and cp32-8 plasmids but otherwise contained the other expected B. burgdorferi plasmids (data not shown) (24). Chromosomal DNA fragments in these two relBbu mutants were PCR amplified with primers relBbu6kbL and relBbu6kbR (Fig. 1), and the deletion of relBbu was confirmed by DNA sequencing. Both mutants were fully characterized genetically and functionally. Identical results were obtained with both; only the data generated from one of them is shown below. Deletion of the relBbu gene did not prevent mRNA expression of the downstream BB0199 gene (Fig. 1). Its RNA could be detected by RT-PCR in wild-type and
relBbu B. burgdorferi (Fig. 2B), showing the absence of a polar effect of the relBbu mutation.
![]() View larger version (35K): [in a new window] |
FIG. 2. Confirmation of relBbu deletion and complementation in B. burgdorferi. (A) PCR analysis of the B. burgdorferi wild type (wt), relBbu mutant ( relBbu), vector-transformed relBbu mutant ( relBbu/pKFSS1), and complemented mutant ( relBbu/pKFSS1-relBbu) with primers R/SpPROT1S and R/SpPROT1EndA (Fig. 1; Table 1). , reaction with DNA omitted. (B) RT-PCR analysis of mRNA expression for BB0199 gene in the B. burgdorferi wild-type (wt) and relBbu mutant ( relBbu). , reaction with mRNA omitted; +RT, reaction with reverse transcriptase; RT, reaction with reverse transcriptase omitted. (C) BamHI-PstI-digested plasmid DNA isolated from E. coli transformed with DNA from vector-transformed ( relBbu/pKFSS1) or complemented ( relBbu/pKFSS1-relBbu) relBbu mutant and BamHI-PstI-digested plasmids used for original transformation of B. burgdorferi (pKFSS1, pKFSS1-relBbu). (D) Competitive PCR analysis of relBbu gene copy number between B. burgdorferi wild-type (wt) and complemented relBbu mutant ( relBbu/pKFSS1-relBbu). Reaction mixtures contained the same amount of total B. burgdorferi DNA and six serial twofold dilutions of competitor (lanes 1 to 6). Lane 4 shows equal signal intensities from target DNA (upper band) and competitor (lower band) for the wild type and the complemented relBbu mutant, indicating that they are present in equal concentrations in this reaction mixture. , negative control.
|
relBbu strain was electroporated with pKFSS1-relBbu carrying the relBbu gene under its own promoter or with the empty pKFSS1 cloning vector as a control. The presence of the wild-type and deleted relBbu alleles was determined by PCR analysis of the complemented B. burgdorferi derivatives using primers R/SpPROT1S and R/SpPROT1EndA (Fig. 1). The mutant complemented with pKFSS1-relBbu produced both mutant- and wild-type-sized amplicons, while the strain transformed with the pKFSS1 cloning vector produced only the mutant-sized amplicon (Fig. 2A). To demonstrate that the plasmids used for complementation were not modified in B. burgdorferi, DNA from complemented B. burgdorferi derivatives was transformed into E. coli. Restriction analysis confirmed that plasmid DNA from spectinomycin-resistant E. coli clones and plasmid DNA originally used for complementation were identical (Fig. 2C).
Detection of relBbu mRNA and RelBbu protein.
RT-PCR analysis showed that relBbu mRNA was produced in wild-type B. burgdorferi grown in BSK-H at 34°C, while the relBbu mutant had no relBbu mRNA synthesis (Fig. 3). Transformation of
relBbu with the pKFSS1-relBbu plasmid but not with the pKFSS1 cloning vector restored relBbu mRNA synthesis in the mutant (Fig. 3).
![]() View larger version (40K): [in a new window] |
FIG. 3. relBbu mRNA synthesis in the B. burgdorferi wild type (wt), relBbu mutant ( relBbu), vector-transformed relBbu mutant ( relBbu/pKFSS1), and complemented mutant ( relBbu/pKFSS1-relBbu). RT-PCR for constitutively expressed flaB gene was used as a control to show the presence of RNA in a sample. , RT-PCR in the absence of mRNA; +RT, reaction containing reverse transcriptase; RT, reaction in the absence of reverse transcriptase. Arrows indicate PCR fragments corresponding to relBbu or flaB mRNA.
|
relBbu (Fig. 4B) and reappeared in lysates of
relBbu transformed with pKFSS1-relBbu. Transformation with the pKFSS1 vector alone did not restore RelBbu synthesis in
relBbu (Fig. 4B). The intensity of the RelBbu band detected in the complemented derivative with pKFSS1-relBbu was stronger than that detected in wild-type B. burgdorferi (Fig. 4B). Image analysis of six independent Western blots indicated that the intensity of this band was threefold greater in the complemented relBbu mutant than in wild-type B. burgdorferi, suggesting increased synthesis of RelBbu protein in complemented B. burgdorferi (Fig. 4C).
![]() View larger version (19K): [in a new window] |
FIG. 4. RelBbu protein synthesis in the B. burgdorferi wild type (wt), relBbu mutant ( relBbu), vector-transformed relBbu mutant ( relBbu/pKFSS1), and complemented mutant ( relBbu/pKFSS1-relBbu). (A) Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (silver stain) of total B. burgdorferi lysates shows that the load of total protein is similar for each lane. (B) Western blot analysis with anti-RelBbu antibodies. (C) Relative RelBbu band intensities estimated from six independent Western blots and presented as means ± standard deviations.
|
(p)ppGpp synthesis.
Both ppGpp and pppGpp could be easily detected in thin-layer chromatograms in wild-type B. burgdorferi 297 grown at 34°C in BSK-H. Spots corresponding to ppGpp or pppGpp were not detected in the relBbu mutant (Fig. 5A and B), while (p)ppGpp synthesis was restored in
relBbu complemented with pKFSS1-relBbu. There was no ppGpp nor pppGpp in the mutant transformed with the empty pKFSS1 vector (Fig. 5A and B). (p)ppGpp levels, as indicated by the intensity of the spots, appeared to be the same in wild-type and complemented B. burgdorferi despite the different amounts of RelBbu protein in these two strains. These results confirm that relBbu is involved in (p)ppGpp synthesis in B. burgdorferi.
![]() View larger version (59K): [in a new window] |
FIG. 5. (p)ppGpp synthesis in the B. burgdorferi wild type (wt), relBbu mutant ( relBbu), vector-transformed relBbu mutant ( relBbu/pKFSS1), and complemented mutant ( relBbu/pKFSS1-relBbu). (A) One-dimensional TLC; (B) two-dimensional TLC. The identities of B. burgdorferi pppGpp and ppGpp were determined by comigration on chromatograms with (p)ppGpp of E. coli (3). Pi, inorganic phosphate.
|
relBbu mutant, and the complemented mutant at 34°C in BSK-H (Fig. 6). Figure 6A shows that there was little difference in cell numbers between the wild type and the relBbu mutant during the first 8 days of culture. The average doubling time was 5.2 h for wild-type B. burgdorferi 297 and 7.8 h for the relBbu mutant during this time, but this difference was not statistically significant (analysis of variance, P > 0.05). However, at 10 to 14 days of culture, when the cultured cells were approaching stationary phase, cell densities in the wild-type cultures were approximately 10-fold greater than those in
relBbu, and this difference was significant (analysis of variance, P < 0.01). Complementation of the relBbu mutant with pKFSS1-relBbu increased stationary-phase cell densities significantly, about fourfold, at 10 to 14 days, but a significant twofold difference in cell densities between complemented and wild-type cell remained (analysis of variance, P < 0.01). There was no difference in cell growth between
relBbu and
relBbu transformed with pKFSS1 vector alone.
![]() View larger version (13K): [in a new window] |
FIG. 6. Growth of the B. burgdorferi wild type (wt), relBbu mutant ( relBbu), vector-transformed relBbu mutant ( relBbu/pKFSS1), and complemented mutant ( relBbu/pKFSS1-relBbu) in BSK-H at 34°C. (A) Growth curves of the B. burgdorferi wild type (closed circles), relBbu mutant (open squares), vector-transformed relBbu mutant (open diamonds), and complemented mutant (closed squares). The numbers of cells/ml of culture were calculated from the results from two independent experiments in duplicate and presented as means ± standard deviations for the corresponding day of incubation. (B) Survival index (as a percentage) = viable cells/mlDay 30 (by limiting dilution)/total cells/mlday 14 (by microscopy) x 100. The survival index is presented as the mean ± standard deviation calculated from the results from two independent experiments in duplicate.
|
Expression of bmp genes. bmpD is transcribed together with the ribosomal protein genes rpsL and rpsG, and its expression might be modulated by the stringent response (3, 11). Measurement of bmp mRNA by competitive RT-PCR showed no differences in transcription of bmpA, bmpB, bmpC, and bmpD genes between the wild type and the relBbu mutant of B. burgdorferi (data not shown), indicating that bmp gene transcription is not modulated by (p)ppGpp.
Effects of temperature shift on OspC production.
B. burgdorferi increases OspC levels when B. burgdorferi is transferred from 23°C to 34 to 37°C conditions of growth (42, 45). RpoS has been shown to be responsible both for this increase in OspC levels with a shift in temperature and for activation of transcription from the ospC promoter at elevated temperatures (22). Because (p)ppGpp is a positive regulator of RpoS in E. coli (16), ablation of (p)ppGpp synthesis in the relBbu mutant might alter the expression pattern of OspC. OspC protein was produced at 34°C and 37°C and was essentially absent at 23°C in mid-log-phase wild-type and
relBbu cultures grown in vitro in BSK-H (Fig. 7A). However, OspC levels were at least twofold lower in the relBbu mutant than in wild-type B. burgdorferi grown at elevated temperatures (Fig. 7A). To determine whether (p)ppGpp was needed for high-level OspC expression, OspC levels in wild-type,
relBbu, and complemented B. burgdorferi were determined in organisms grown at 37°C to early stationary phase, where the difference in growth between the wild type and the relBbu mutant might further increase any possible effect of (p)ppGpp on OspC expression. Stationary-phase OspC levels were higher in wild-type B. burgdorferi grown at 37°C than in the relBbu mutant (Fig. 7B), confirming the results obtained with mid-log-phase cultures, but complementation of the relBbu mutant did not raise OspC levels, suggesting that (p)ppGpp is not involved in regulation of OspC synthesis. RpoS was detected in the immunoblots of the wild-type and relBbu mutant B. burgdorferi growing at elevated temperature but not at 23°C (data not shown), indicating that RpoS expression does not require (p)ppGpp.
![]() View larger version (26K): [in a new window] |
FIG. 7. Temperature shift in the B. burgdorferi wild type (wt), relBbu mutant ( relBbu), vector-transformed relBbu mutant ( relBbu/pKFSS1), and complemented mutant ( relBbu/pKFSS1-relBbu). (A) Western blots for FlaB, OspA, and OspC in B. burgdorferi wild-type and relBbu mutant mid-log-phase cultures in BSK-H at 23°C, 34°C, and 37°C. OspC levels in the B. burgdorferi wild type and relBbu mutant in mid-log-phase cultures in BSK-H at 23°C, 34°C, and 37°C were estimated from the results from four independent Western blots and presented as means ± standard deviations. (B) Western blots for FlaB and OspC in wild-type, relBbu mutant, and complemented B. burgdorferi from early-stationary-phase cultures grown in BSK-H at 37°C. OspC levels in wild-type, relBbu mutant, and complemented B. burgdorferi from early-stationary-phase cultures grown in BSK-H at 37°C were compared from four different Western blots and presented as means ± standard deviations. Similar intensities of FlaB bands in panels A and B show similar protein loads for each lane.
|
|
View this table: [in a new window] |
TABLE 2. MICs of antibiotics for wild-type, relBbu mutant, and complemented B. burgdorferi
|
relBbu, and complemented B. burgdorferi.
C3H/HeN mice were infected intradermally with the B. burgdorferi 297 wild type, relBbu mutant, relBbu mutant transformed with pKFSS1, or relBbu mutant complemented with pKFSS1-relBbu. All the strains used for infection had been shown to carry all plasmids of the parental B. burgdorferi 297 (data not shown). Two weeks after infection, B. burgdorferi could be cultured only from ear punches and blood samples of mice injected with wild-type B. burgdorferi (four of five positive ear punch cultures and five of five positive blood cultures). B. burgdorferi could not be cultured from ear punches and blood of any of the mice receiving
relBbu or its derivatives transformed with pKFSS1 or pKFSS1-relBbu. |
|
|---|
The relBbu gene and (p)ppGpp are not essential for in vitro growth of B. burgdorferi, since the relBbu mutant was able to multiply in BSK-H (Fig. 6). B. burgdorferi thus differs from Staphylococcus aureus, since rel mutants cannot be isolated in S. aureus because the relSau gene and (p)ppGpp are essential in this species (14). Nevertheless, the relBbu mutant did show an important growth defect because it only achieved 1/10 the cell concentration of wild-type B. burgdorferi in the stationary phase in vitro. It is not clear whether this growth defect resulted from a decrease in growth during the exponential phase or is a result of the inability of this mutant to thrive during the stationary phase, since the mutant does not display increased cell death during the stationary phase (Fig. 6). The growth deficit of B. burgdorferi lacking (p)ppGpp is quite different from that of E. coli lacking (p)ppGpp. In E. coli, experimental evidence indicates that (p)ppGpp can suppress expression of the ftsZ gene, an essential gene for cell division and septation (35), and the level of (p)ppGpp is inversely correlated with the rate of initiation of new rounds of DNA replication (40).
We previously reported that lack of (p)ppGpp synthesis in B. burgdorferi grown in the presence of tick cells was associated with changes in the transcription of bmpD, a gene transcribed with the ribosomal protein genes rpsL and rpsG, compared to that seen in B. burgdorferi grown in BSK-H (3, 11). Unexpectedly, we found no alteration of bmp gene expression in the relBbu mutant compared to wild-type B. burgdorferi, indicating that perhaps the changes seen in the expression of these genes during B. burgdorferi growth in the presence of tick cells were more the result of their interaction with the tick cells than of the disappearance of (p)ppGpp (3). More extensive experiments to examine bmp gene modulation in the relBbu mutant and its complemented derivatives growing in the presence of tick cells will be needed to clarify these differences.
It is well established that (p)ppGpp can regulate gene expression in E. coli through a positive control cascade mediated by the alternative bacterial
factor RpoS (6). RpoS is involved in the OspC temperature-mediated shift in B. burgdorferi (22), which has been shown to be important for transmission of B. burgdorferi from ticks to mammals (18, 33). Although OspC expression decreased in B. burgdorferi
relBbu, the OspC temperature shift was not eliminated by the lack of (p)ppGpp. This suggests that (p)ppGpp does not modulate RpoS functions in B. burgdorferi. Detection of RpoS in immunoblots in the wild-type 297 and
relBbu strains (data not shown) also confirmed that RpoS expression does not require (p)ppGpp. The absence of modulation of RpoS-dependent genes by (p)ppGpp in B. burgdorferi is surprising, since there is a homologue of dksA in the B. burgdorferi genome (BB0168) (13) whose gene product mediates RpoS induction by (p)ppGpp in E. coli (2). An absence of modulation of RpoS levels by (p)ppGpp has also been found in S. enterica serovar Typhimurium (34), where (p)ppGpp can modulate expression of virulence-associated genes by an RpoS-independent pathway (34). A recent report has proposed that there are RpoS-independent virulence regulons in B. burgdorferi (5) and that (p)ppGpp may have a role in their regulation, but this requires further study.
(p)ppGpp mediates resistance of E. coli to various antibiotics by lowering bacterial metabolism and growth rate as well as by RpoS activation (17, 19, 36). Our experiments indicate that the MICs of several classes of antibiotics are similar in B. burgdorferi in the presence and absence of (p)ppGpp (Table 2). The absence of this phenotype could be explained by the fact that, in contrast to what occurs in E. coli, the lack of (p)ppGpp did not change the B. burgdorferi growth rate substantially and did not affect the synthesis of RpoS, two elements involved in (p)ppGpp-mediated antibiotic resistance in E. coli. The decreased MIC of ciprofloxacin observed in the relBbu mutant and its complemented derivative could be the result of a spontaneous mutation. Alternatively, the difference in cell densities between complemented and wild-type B. burgdorferi strains might be responsible for the increased susceptibility to ciprofloxacin in the complemented strain.
Since mutation of rel has been shown to affect virulence in several bacterial pathogens (8, 20, 34), we compared the ability of wild-type,
relBbu, and complemented B. burgdorferi to infect mice after needle inoculation. The loss of infectivity for
relBbu suggested that relBbu is necessary for B. burgdorferi to produce infection in mice. Since complementation, even in the presence of all parental B. burgdorferi plasmids, did not restore infectivity in mice, there is a possibility of a defect that cannot be determined by the present techniques. This suggests that other complementation approaches (for example, intrachromosomal) might be needed to confirm that (p)ppGpp is involved in B. burgdorferi virulence. The decreased levels of OspC, a major lipoprotein necessary for infection of mammalian hosts (18, 33), might partially explain the loss of infectivity in the relBbu mutant, although complementation restored neither OspC levels nor infectivity. Increased RelBbu levels in complemented B. burgdorferi, even though they did not lead to increased (p)ppGpp amounts, might be responsible for the failure of the complementation to restore infectivity in mice. Another explanation for the failure of complementation to restore the infectiousness of the
relBbu strain could be loss of the complementing plasmid harboring the relBbu wild-type gene in mice (12).
In summary, we have shown that relBbu is responsible for (p)ppGpp synthesis and affects the growth and probably the infectivity of B. burgdorferi. Our work also provides evidence that the absence of (p)ppGpp in B. burgdorferi was not accompanied by the same phenotypes as in E. coli. This suggests that the role of this mediator in B. burgdorferi physiology is different from its role in E. coli. Our results indicate that (p)ppGpp does not regulate RpoS-dependent promoters and does not influence susceptibility to antibiotics in B. burgdorferi. Further studies will be needed to ascertain the role of (p)ppGpp in B. burgdorferi and to define the stringent response in this pathogen.
We thank M. Cashel, National Institutes of Health, Bethesda, MD, for advice and discussions; M. V. Norgard, University of Texas Southwestern Medical Center, Dallas, TX, for B. burgdorferi 297, clone BbAH130, and anti-RpoS antibodies; D. S. Samuels, University of Montana, Missoula, MT, for pKFSS1; J. D. Radolf, C. H. Eggers, and M. J. Caimano, University of Connecticut, Farmington, CT, for anti-FlaB antibodies and for extensive discussions; A. G. Barbour, University of California, Irvine, CA, for anti-OspA antibodies (H5332); and R. D. Gilmore, CDC, Fort Collins, CO, for anti-OspC antibodies. We also thank Radha Iyer and Darya Terekhova, New York Medical College, Valhalla, NY, for help with analysis of B. burgdorferi plasmid composition.
|
|
|---|
s is positively regulated by ppGpp. J. Bacteriol. 175:7982-7989.
s. Lett. Appl. Microbiol. 29:323-326.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»